Extramedullary molecular evidence of the 5′KIAA1509/3′PDGFRB fusion gene in chronic eosinophilic leukemia

Leukemia Research

Volumn 32, Issue 2, 2008, Pages 347-351

  Albano, Francesco ^a   Anelli, Luisa ^a   Zagaria, Antonella ^a   Lonoce, Angelo ^a   La Starza, Roberta ^b   Liso, Vincenzo ^a   Rocchi, Mariano ^a   Specchia, Giorgina ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Chronic eosinophilic leukemia; Extramedullary site; KIAA1509; PDGFRB; Repetitive DNA

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; REPETITIVE DNA;

ADULT; ALU SEQUENCE; ARTICLE; CASE REPORT; CHROMOSOME REARRANGEMENT; CHRONIC LEUKEMIA; CONTROLLED STUDY; EOSINOPHILIC LEUKEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE; GENE LOCATION; HUMAN; INTRON; KIAA1509 GENE; MOLECULAR CLONING; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CHRONIC DISEASE; FEMALE; GENE FUSION; HUMANS; HYPEREOSINOPHILIC SYNDROME; MOLECULAR SEQUENCE DATA; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-SIS; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 38949160767     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.06.016     Document Type: Article

References (21)

1. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
2. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
3. Abe A., Emi N., Tanimoto M., Terasaki H., Marunouchi T., and Saito H. Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood 90 (1997) 4271-4277
4. Wilkinson K., Velloso E.R., Lopes L.F., Lee C., Aster J.C., Shipp M.A., et al. Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib. Blood 102 (2003) 4187-4190
5. Grand F.H., Burgstaller S., Kuhr T., Baxter E.J., Webersinke G., Thaler J., et al. p53-Binding protein 1 is fused to the platelet-derived growth factor receptor in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder. Cancer Res 64 (2004) 7216-7219
6. Gotlib J., Cools J., Malone III J.M., Schrier S.L., Gilliland D.G., and Coutre S.E. The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 103 (2004) 2879-2891
7. Score J., Curtis C., Waghorn K., Stalder M., Jotterand M., Grand F.H., et al. Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia. Leukemia 20 (2006) 827-832
8. Cross N.C.P., and Reiter A. Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia 16 (2002) 1207-1212
9. Morerio C., Acquila M., Rosanda C., Rapella A., Dufour C., Locatelli F., et al. HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2). Cancer Res 64 (2004) 2649-2651
10. Vizmanos J.L., Novo F.J., Roman J.P., Baxter E.J., Lahortiga I., Larrayoz M.J., et al. NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder. Cancer Res 64 (2004) 2673-2676
11. Levine R.L., Wadleigh M., Sternberg D.W., Wlodarska I., Galinsky I., Stone R.M., et al. KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). Leukemia 19 (2005) 27-30
12. Lichter P., Tang C.J., Call K., Hermanson G., Evans G.A., Housman D., et al. High resolution mapping of human chromosomes 11 by in situ hybridization with cosmid clones. Science 247 (1990) 64-69
13. Marchler-Bauer A., Anderson J.B., Cherukuri P.F., DeWeese-Scott C., Geer L.Y., Gwadz M., et al. CDD: a Conserved Domain Database for protein classification. Nucleic Acids Res 33 (2005) D192-D196
14. Kramer H., and Phistry M. Genetic analysis of hook, a gene required for endocytic trafficking in drosophila. Genetics 151 (1999) 675-684
15. Krendel M., and Mooseker M.S. Myosins: tails (and heads) of functional diversity. Physiology 20 (2005) 239-251
16. Harvey S.H., Krien M.J.E., and O'Connell M.J. Structural maintenance of chromosomes (SMC) proteins, a family of conserved ATPases. Genome Biology 3 (2002) 3003.1-3003.5
17. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
18. Kolomietz E., Meyn M.S., Pandita A., and Squire J.A. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35 (2002) 97-112
19. Pitini V., Sturniolo G., Cavallari V., and Arrigo C. Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib. Br J Haematol 132 (2006) 123
20. Muller A.M., Martens U.M., Hofmann S.C., Bruckner-Tuderman L., Mertelsmann R., and Lubbert M. Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature. Ann Hematol 85 (2006) 1-16
21. Stover E.H., Chen J., Folens C., Lee B.H., Mentens N., Marynen P., et al. Activation of FIP1L1-PDGFR requires disruption of the juxtamembrane domain of PDGFR and is FIP1L1-independent. PNAS 103 (2006) 8078-8083